Allogene Therapeutics, Inc. (ALLO) — Analyst estimates
Consensus analyst estimates for Allogene Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 2.22K | -0.18 | 1 |
| 2027 | 6.67K | -0.23 | 1 |
| 2028 | 77.65M | -0.69 | 10 |
| 2029 | 311.76M | -0.11 | 4 |
| 2030 | 606.67M | 0.75 | 4 |
Consensus analyst estimates by fiscal year.